12/16/2019 2:03:20 AM
AstraZeneca Completes Deal With Cheplapharm For Rights To Seroquel
and Seroquel XR In Europe And Russia
12/12/2019 2:19:24 AM
AstraZeneca Says Imfinzi Approved In China For Unresectable, Stage III NSCLC
12/11/2019 8:12:00 AM
AstraZeneca, Daiichi Sankyo Present Positive Detailed Data From Pivotal Phase II Single-arm DESTINY-Breast01 Trial
12/9/2019 2:24:48 AM
DeepMatter Announces Collaboration With AstraZeneca
12/5/2019 2:03:02 AM
AstraZeneca Says Lynparza Approved In China As 1st-line Maintenance Therapy In BRCA-mutated Advanced Ovarian Cancer
12/3/2019 2:24:45 AM
AstraZeneca Divests Rights To Seroquel And Seroquel XR In The US And Canada
11/29/2019 2:02:52 AM
AstraZeneca Says FDA Accepts SBLA And Granted Priority Review For Imfinzi
11/17/2019 12:01:59 PM
AZN : TWILIGHT Trial Shows BRILINTA Monotherapy Reduced Risk Of Relevant Bleeding Compared To Dual Antiplatelet Therapy
11/17/2019 10:52:42 AM
AstraZeneca : FARXIGA Reduces Risk Of Primary Composite Outcome Of Worsening Heart Failure
11/15/2019 2:03:52 AM
AstraZeneca: EC Approves Qtrilmet For The Treatment Of Type-2 Diabetes
11/14/2019 8:10:01 AM
AstraZeneca Announces Launch Of Diabetes Can Break Your Heart National Movement
11/14/2019 2:10:53 AM
AstraZeneca : FDA Accepts Regulatory Submission For Selumetinib In Neurofibromatosis Type 1 And Grants Priority Review